These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3766279)

  • 1. Role of parenchymal versus non-parenchymal cells in the control of biologically reactive intermediates.
    Oesch F; Lafranconi M; Glatt HR
    Adv Exp Med Biol; 1986; 197():53-61. PubMed ID: 3766279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenobiotic metabolizing enzymes of rat liver nonparenchymal cells.
    Lafranconi WM; Glatt H; Oesch F
    Toxicol Appl Pharmacol; 1986 Jul; 84(3):500-11. PubMed ID: 3088773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rat liver parenchymal and nonparenchymal cells in the activation of promutagens.
    Teepe AG; Beck DJ; Li AP
    Environ Mol Mutagen; 1992; 20(2):134-9. PubMed ID: 1505529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of carcinogen metabolizing enzymes in the mouse liver: comparison of parenchymal and non-parenchymal cell populations.
    Steinberg P; Lafranconi WM; Oesch F
    Arch Toxicol Suppl; 1987; 10():148-56. PubMed ID: 3472497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolizing systems in short-term in vitro tests for carcinogenicity.
    Platt KL; Utesch D; Gemperlein-Mertes I; Glatt HR; Oesch F
    Food Chem Toxicol; 1986; 24(6-7):721-9. PubMed ID: 3781425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of biphenyl ethers on the hepatic mixed--function oxidase (MFO) systems and on the conversion of procarcinogens to mutagens.
    Miyauchi M; Uematsu T
    Bull Environ Contam Toxicol; 1990 Sep; 45(3):422-9. PubMed ID: 2257338
    [No Abstract]   [Full Text] [Related]  

  • 8. Rat liver endothelial and Kupffer cell-mediated mutagenicity of polycyclic aromatic hydrocarbons and aflatoxin B1.
    Steinberg P; Schlemper B; Molitor E; Platt KL; Seidel A; Oesch F
    Environ Health Perspect; 1990 Aug; 88():71-6. PubMed ID: 2125561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of reactive metabolites of procarcinogens between different liver cell types, as demonstrated by the single cell microgel electrophoresis assay.
    Kuchenmeister F; Wang M; Klein RG; Schmezer P
    Toxicol Lett; 1996 Nov; 88(1-3):29-34. PubMed ID: 8920713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of parenchymal and non-parenchymal liver cells to the clearance of hepatocyte growth factor from the circulation in rats.
    Liu KX; Kato Y; Terasaki T; Aoki S; Okumura K; Nakamura T; Sugiyama Y
    Pharm Res; 1995 Nov; 12(11):1737-40. PubMed ID: 8592679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung and liver cell-mediated mutagenesis systems: specificities in the activation of chemical carcinogens.
    Langenbach R; Nesnow S; Tompa A; Gingell R; Kuszynski C
    Carcinogenesis; 1981; 2(9):851-8. PubMed ID: 6271413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of aromatic amines to mutagens by bovine bladder and liver cells.
    Oglesby L; Hix-Baker C; MacNair P; Sieg M; Snow L; Langenbach R
    Environ Health Perspect; 1983 Mar; 49():147-54. PubMed ID: 6339223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of chronic alcohol administration to rats on the activation of aromatic amines to mutagens in the Ames test.
    Steele CM; Ioannides C
    Carcinogenesis; 1986 May; 7(5):825-9. PubMed ID: 3009048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity, clastogenicity and cytotoxicity of procarcinogens in a rat hepatoma cell line competent for xenobiotic metabolism.
    Roscher E; Wiebel FJ
    Mutagenesis; 1988 May; 3(3):269-76. PubMed ID: 3045489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): formation of 2-hydroxamino-PhIP, a directly acting genotoxic metabolite.
    Holme JA; Wallin H; Brunborg G; Søderlund EJ; Hongslo JK; Alexander J
    Carcinogenesis; 1989 Aug; 10(8):1389-96. PubMed ID: 2665964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic inactivation of mutagenic benzo(a)pyrene metabolites: significance to carcinogenicity and implications for in vitro tests.
    Glatt HR; Platt KL; Vogel K; Bücker M; Billings R; Oesch F
    Dev Toxicol Environ Sci; 1980; 8():181-6. PubMed ID: 6273103
    [No Abstract]   [Full Text] [Related]  

  • 20. Detoxification of genotoxic compounds as a threshold mechanism limiting their carcinogenicity.
    De Flora S
    Toxicol Pathol; 1984; 12(4):337-43. PubMed ID: 6442795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.